中文韩国午夜理伦三级好看,亚洲公开免费在线视频

首頁(yè)> 產(chǎn)品列表> 抗感染類(lèi)抑制劑單純皰疹病毒抑制劑>

曲金剛胺

NMR下載 COA and HPLC MSDS下載
names：
Tromantadine
CAS號(hào)：
53783-83-8
MDL Number： MFCD00869480
MF(分子式)： C16H28N2O2 MW(分子量)： 280.41
EINECS:258-770-0 Reaxys Number:
Pubchem ID:64377 Brand:BIOFOUNT

曲金剛胺(53783-83-8,Tromantadine)是Amantadine衍生物，具有抗皰疹活性，曲金剛胺可抑制單純皰疹病毒1型（HSV-1）和HSV-2的復(fù)制。

貨品編碼	規(guī)格	純度	價(jià)格 (￥)	現(xiàn)價(jià)(￥)	特價(jià)(￥)	庫(kù)存描述	數(shù)量	總計(jì) (￥)
YZM000720-5mg	5mg	>99.0%	￥ 5062.00	￥ 5062.00		Backorder	- +	￥ 0.00
YZM000720-1mg	1mg	>99.0%	￥ 1950.00	￥ 1950.00		2-3天	- +	￥ 0.00

大包裝詢(xún)價(jià) 提供各種包裝，敬請(qǐng)垂詢(xún)
收藏商品商品點(diǎn)評(píng) 加入購(gòu)物車(chē) 立即購(gòu)買(mǎi)

快速詢(xún)價(jià)

收起

你想詢(xún)價(jià)的產(chǎn)品

*產(chǎn)品名稱(chēng)：

CAS號(hào)：

產(chǎn)品編號(hào)：

需求描述：

請(qǐng)準(zhǔn)確填寫(xiě)您的聯(lián)系方式，以便為您提供最好的服務(wù)。

*公司名稱(chēng)：

*電子郵箱：

聯(lián)系人：

*電話(huà)：

*驗(yàn)證碼：

詢(xún)價(jià)

中文別名	曲金剛胺(53783-83-8);D 41;曲曼他定;N-（1-金剛烷基）-2-（2-二甲基氨基乙氧基）乙酰胺;姜黃素;曲曼他定'鹽酸金剛烷胺;一水合鹽酸金剛烷胺，一水合物;甘露定;維魯·梅爾茲;維魯·梅爾茲·塞羅爾;塞魯爾;
英文別名	Tromantadine(53783-83-8);D 41;N-(1-adamantyl)-2-(2-dimethylaminoethoxy)acetamide;tromantadin;tromantadine;tromantadine monohydrochloride;tromantadine monohydrochloride, monohydrate;tromantidine;Viru-Merz;Viru-Merz serol;Viru-Serol;
CAS號(hào)	53783-83-8
Inchi	InChI=1S/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19)
InchiKey	UXQDWARBDDDTKG-UHFFFAOYSA-N
分子式 Formula	C16H28N2O2
分子量 Molecular Weight	280.41
溶解度Solubility
性狀	Solid
儲(chǔ)藏條件 Storage conditions	存放在陰涼干燥處Pure form -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月

曲金剛胺(53783-83-8,Tromantadine)實(shí)驗(yàn)注意事項(xiàng)：
1.實(shí)驗(yàn)前需戴好防護(hù)眼鏡，穿戴防護(hù)服和口罩，佩戴手套，避免與皮膚接觸。
2.實(shí)驗(yàn)過(guò)程中如遇到有毒或者刺激性物質(zhì)及有害物質(zhì)產(chǎn)生，必要時(shí)實(shí)驗(yàn)操作需要手套箱內(nèi)完成以免對(duì)實(shí)驗(yàn)人員造成傷害
3.實(shí)驗(yàn)后產(chǎn)生的廢棄物需分類(lèi)存儲(chǔ)，并交于專(zhuān)業(yè)生物廢氣物處理公司處理，以免造成環(huán)境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.

Tags：曲金剛胺試劑,曲金剛胺雜質(zhì),曲金剛胺中間體,曲金剛胺密度,曲金剛胺熔點(diǎn),曲金剛胺閃點(diǎn),曲金剛胺合成,曲金剛胺結(jié)構(gòu)式,曲金剛胺購(gòu)買(mǎi),曲金剛胺MSDS,

產(chǎn)品說(shuō)明	曲金剛胺(53783-83-8,Tromantadine)是一種有效的單純皰疹病毒 (HSV) 的抑制劑
Introduction	曲金剛胺(53783-83-8,Tromantadine) is a herpes simplex virus (HSV) inhibitor.
Application1	曲金剛胺是具有抗皰疹活性的金剛烷胺衍生物，可抑制單純皰疹病毒1型（HSV-1）和HSV-2復(fù)制
Application2	Tromantadine是一種局部抗皰疹藥物，對(duì)單純皰疹病毒1型（HSV-1）復(fù)制具有兩個(gè)獨(dú)立的作用：早期，在病毒結(jié)合或穿透過(guò)程中，晚期，在DNA合成開(kāi)始后。
Application3

曲金剛胺(53783-83-8,Tromantadine)藥理學(xué)：

1、曲金剛胺是一種環(huán)狀胺，具有抗單純皰疹病毒的活性。Tromantadine抑制病毒體吸收到細(xì)胞表面，以及病毒的滲透和脫膜。 Tromantadine在捷克共和國(guó)的市場(chǎng)名為Viru-Merz。曲金剛胺是一種抗病毒藥，用于治療帶狀皰疹和單純性皰疹。

2、曲金剛胺是抗病毒劑，曲金剛胺用于預(yù)防或治療病毒性疾病的藥物。曲金剛胺可能發(fā)揮作用的方式包括通過(guò)抑制病毒DNA聚合酶來(lái)防止病毒復(fù)制。曲金剛胺與特定的細(xì)胞表面受體結(jié)合并抑制病毒滲透或脫殼；抑制病毒蛋白質(zhì)合成；或阻止病毒組裝的后期。

警示圖
危險(xiǎn)性	warning
危險(xiǎn)性警示	Not available
安全聲明	H303吞入可能有害+H313皮膚接觸可能有害+H2413吸入可能對(duì)身體有害
安全防護(hù)	P264處理后徹底清洗+P280戴防護(hù)手套/穿防護(hù)服/戴防護(hù)眼罩/戴防護(hù)面具+P305如果進(jìn)入眼睛+P351用水小心沖洗幾分鐘+P338取出隱形眼鏡（如果有）并且易于操作,繼續(xù)沖洗+P337如果眼睛刺激持續(xù)+P2393獲得醫(yī)療建議/護(hù)理
備注	實(shí)驗(yàn)過(guò)程中防止吸入、食入，做好安全防護(hù)

Rosenthal KS, et al. Tromantadine: inhibitor of early and late events in herpes simplex virus replication. Antimicrob Agents Chemother. 1982 Dec;22(6):1031-6.

Cheetham JJ, et al. Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with model phospholipid membranes. Biosci Rep. 1987 Mar;7(3):225-30.

Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with model phospholipid membranes Bioscience Reports 1987

Tromantadine Reactions Weekly 2018

Aciclovir and tromantadine have comparable efficacy InPharma 1989

曲金剛胺(53783-83-8,Tromantadine)參考文獻(xiàn)：

1.Separation methods for tricyclic antiviral drugs.
Suckow RF1. J Chromatogr B Biomed Sci Appl. 2001 Nov 25;764(1-2):313-25.

A review of the published analytical methodology for the tricyclic antiviral (TAV) drugs is presented. While amantadine and rimantadine are the only two approved drugs for the prophylaxis and treatment of the influenza A virus, amantadine has also been approved for the treatment of Parkinson's disease. In addition, a few structurally related compounds are finding important clinical applications in other central nervous system-related disorders. To effectively evaluate the pharmacokinetics, biotransformations, stability, and other critical parameters that are necessary for pre-clinical and clinical studies, analytical methodology that conforms to the rigors of regulatory requirements must be developed and made available. This review discusses the analytical methods used in the determination of amantadine, rimantadine, tromantadine and memantine and the pre-clinical and clinical application of these techniques.

2.Topical tromantadine in the treatment of genital herpes. A double-blind placebo controlled study.
Petersen CS1, Weismann K, Avnstorp C, Rasmussen LP, Fogh H, Tikjøb G. Dan Med Bull. 1993 Sep;40(4):506-7.

A randomised double-blind placebo controlled trial was performed to assess the efficacy and safety of tromantadine ointment 1% in male patients with genital herpes. 45 patients with penile genital herpes of less than three days duration were randomised to local treatment with tromantadine ointment 1% or placebo (ointment base alone) five times daily up to 12 days. No difference in time of healing could be detected between the two groups (p = 1.0). Both the objective signs (vesicles, pustules, ulceration, and glandular swelling) and the subjective symptoms (itching, burning, pain and dysuria) all diminished simultaneously in the two groups.

3.Allergic contact dermatitis from tromantadine.
Jáuregui I1, Urrutia I, Gamboa PM, Antépara I. J Investig Allergol Clin Immunol. 1997 Jul-Aug;7(4):260-1.

Tromantadine is a topical antiviral agent derived from amantadine. In previous reports, 5% of treated patients developed contact allergy. We report the case of a 28-year-old woman who had a sudden worsening of a lip herpes after treatment with a tromantadine ointment, with strong positive patch testing to this substance. The purpose of this paper is to call attention to the fact that tromantadine is still widely used in several European countries as a second-line therapy for lip herpes, and therefore, new cases of sensitization to tromantadine are likely to occur.

對(duì)不起，暫無(wú)產(chǎn)品評(píng)價(jià)！

MSDS

SDS 1.0 中文

展開(kāi)

SDS 1.0 英文

展開(kāi)